Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results

Rhea-AI Summary

Miromatrix Medical Inc. (NASDAQ: MIRO), a leader in bioengineering fully transplantable organs, will announce its fourth quarter and full year 2022 financial results on March 31, 2023, after market close. Management will conduct a conference call at 3:30 PM CT to discuss these results. Interested parties can join the call via domestic and international numbers or through a live webcast on the company's investor relations webpage. Miromatrix focuses on utilizing its proprietary perfusion technology to address the shortage of human organs, specifically developing applications for human livers and kidneys.

EDEN PRAIRIE, Minn., March 15, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that the Company will report financial results for the fourth quarter and full year 2022 after market close on Friday, March 31, 2023. Company management will host a corresponding conference call beginning at 3:30 pm Central Time / 4:30 pm Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 877-407-3982 for domestic callers or 201-493-6780 for international callers. Please reference Conference ID: 13736060. To listen to a live webcast, please visit the investor relations section of Miromatrix's website at: https://miromatrix.gcs-web.com/

About Miromatrix
Miromatrix is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. Miromatrix has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. Miromatrix’s initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

FAQ

When will Miromatrix report its financial results for Q4 and full year 2022?

Miromatrix will report its financial results after market close on March 31, 2023.

What time is the Miromatrix conference call regarding their financial results?

The conference call will begin at 3:30 PM Central Time on March 31, 2023.

How can I listen to the Miromatrix conference call?

You can listen to the Miromatrix conference call by dialing 877-407-3982 for domestic callers or 201-493-6780 for international callers, or by visiting their investor relations website for a live webcast.

What technology does Miromatrix specialize in?

Miromatrix specializes in bioengineering fully transplantable organs using a proprietary perfusion technology platform.